(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 72.19%4.74B | ---- | ---- | ---- | 160.81%2.75B | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | -155.18%-207.05M | ---- | ---- | ---- | -50.74%-81.14M | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | -12.15%-17.73M | ---- | ---- | ---- | -21.51%-15.81M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | -13.92%-1.19B | ---- | ---- | ---- | -7.61%-1.04B | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 27,374.01%1.21B | ---- | ---- | ---- | -99.91%4.4M | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | 2,677.78%7.75M | ---- | ---- | ---- | 104.84%279K | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 29,045.19%1.2B | ---- | ---- | ---- | -98.87%4.12M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | ---11.98M | ---- | ---- | ---- | ---- | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---11.98M | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | -444.97%-402.98M | ---- | ---- | ---- | -231.96%-73.95M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -444.97%-402.98M | ---- | ---- | ---- | -231.96%-73.95M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | 12.34%3.16B | ---- | ---- | ---- | -0.73%2.81B | ---- | ---- |
Financial expense | ---- | ---- | ---- | 46.26%1.45B | ---- | ---- | ---- | 20.24%994M | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 63.29%8.73B | ---- | ---- | ---- | 78.26%5.35B | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 148.42%128.24M | ---- | ---- | ---- | -72.29%-264.87M | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | 140.10%408.12M | ---- | ---- | ---- | -1,198.99%-1.02B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -21.33%270.65M | ---- | ---- | ---- | -21.02%344.03M | ---- | ---- |
prepayments (increase)decrease | ---- | ---- | ---- | -120.06%-14.43M | ---- | ---- | ---- | -48.58%71.94M | ---- | ---- |
Special items for working capital changes | ---- | ---- | ---- | 16,425.37%33.88M | ---- | ---- | ---- | 100.42%205K | ---- | ---- |
Cash from business operations | ---- | ---- | ---- | 113.29%9.56B | ---- | ---- | ---- | 29.30%4.48B | ---- | ---- |
Other taxs | ---- | ---- | ---- | -154.78%-897.89M | ---- | ---- | ---- | -169.62%-352.42M | ---- | ---- |
Special items of business | ---- | -21.75%3.6B | ---- | ---- | ---- | 466.80%4.61B | ---- | ---- | ---- | -49.37%812.85M |
Adjustment items of business operations | -11.83%5.76B | ---- | -22.58%1.43B | ---- | 252.50%6.54B | ---- | 661.82%1.84B | ---- | -18.06%1.85B | ---- |
Net cash from operations | -11.83%5.76B | -21.75%3.6B | -22.58%1.43B | 109.75%8.66B | 252.50%6.54B | 466.80%4.61B | 661.82%1.84B | 23.80%4.13B | -18.06%1.85B | -49.37%812.85M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 6.50%101.54M | ---- | 179.29%226.62M | ---- | 146.53%95.34M | ---- | -11.54%81.14M | ---- | -17.04%38.67M |
Dividend received - investment | -45.18%361.11M | -27.93%332.61M | 3,344.67%156.7M | 10.05%689.65M | 6.87%658.76M | 255.30%461.48M | --4.55M | -13.04%626.68M | 108.10%616.43M | -61.63%129.88M |
Loan receivable (increase) decrease | ---- | 37.95%53.69M | ---- | 175.52%82.08M | ---- | 93.82%38.92M | ---- | -1.49%29.79M | ---- | 10.96%20.08M |
Decrease in deposits (increase) | ---- | 0.00%-1K | ---- | 72.73%-3K | ---- | 0.00%-1K | ---- | -266.67%-11K | ---- | 50.00%-1K |
Sale of fixed assets | -74.49%225.19M | -100.00%5K | ---- | 144.45%885.17M | --882.74M | 702.40%875.59M | --534.66M | 294.08%362.11M | ---- | 11,080.53%109.12M |
Purchase of fixed assets | -96.20%-3.9B | -333.88%-3.94M | 59.80%-571.54M | 88.99%-1.68M | 8.67%-1.99B | 58.19%-909K | -34.20%-1.42B | -1,052.46%-15.22M | -1.90%-2.18B | -1,156.65%-2.17M |
Recovery of cash from investments | 13.11%84.02M | ---- | --10.02M | ---- | 97.10%74.28M | ---- | ---- | ---- | -7.54%37.69M | ---- |
Cash on investment | -200.95%-1.85B | -115.37%-4.82B | -389.55%-1.52B | -3.93%-6.49B | -87.13%-613.79M | -15.38%-2.24B | -196.39%-310.91M | -77.45%-6.24B | ---328.01M | 5.64%-1.94B |
Other items in the investment business | ---- | ---- | -1,559.36%-301.77M | ---- | --300.18M | ---- | 357.87%20.68M | ---- | ---- | ---- |
Adjustment items of investment business | ---- | ---- | ---- | ---- | ---300.18M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -414.82%-5.08B | -464.57%-4.34B | -90.05%-2.23B | 10.71%-4.6B | 46.71%-986.38M | 53.29%-768.33M | -1.21%-1.17B | -99.57%-5.16B | -2.86%-1.85B | 0.46%-1.64B |
Net cash before financing | -87.67%684.01M | -119.09%-732.82M | -219.85%-802.37M | 495.27%4.06B | 191,280.76%5.55B | 561.47%3.84B | 145.04%669.51M | -236.50%-1.03B | -99.37%2.9M | -1,668.86%-831.88M |
Cash flow from financing activities | ||||||||||
New borrowing | -21.62%5.63B | -22.90%3.84B | -86.72%333.12M | -25.22%11.19B | -39.90%7.18B | -37.32%4.98B | -8.66%2.51B | 106.63%14.97B | 124.32%11.95B | 141.95%7.95B |
Refund | 49.28%-4.63B | 49.34%-3.54B | 62.08%-1.1B | -21.54%-11.78B | 6.59%-9.12B | -5.46%-6.99B | -45.23%-2.9B | -38.31%-9.7B | -72.21%-9.77B | -74.56%-6.63B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --46.41M | ---- | ---- |
Interest paid - financing | ---- | 5.42%-667.98M | ---- | -74.00%-1.49B | ---- | -119.03%-706.26M | ---- | 3.15%-854.43M | ---- | 14.41%-322.45M |
Dividends paid - financing | -52.15%-2.75B | -18.84%-135.52M | -13.58%-322.91M | -385.05%-880.52M | -95.31%-1.81B | 19.85%-114.03M | -172.96%-284.29M | 85.34%-181.53M | 39.87%-925.63M | -21.40%-142.27M |
Absorb investment income | ---- | ---- | ---- | 342.05%585.75M | -84.76%27.69M | -85.11%26.64M | --27.18M | 78.14%132.51M | 140.69%181.75M | 140.53%178.91M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | 89.12%-603K | ---- | -27,228.38%-2.5B | ---- | -420.86%-5.54M |
Other items of the financing business | -4.60%-247.42M | 308.60%52.14M | -1,466.77%-94.24M | 25,479.93%77.76M | 22.08%-236.54M | --12.76M | -40.41%-6.01M | --304K | -9.94%-303.59M | ---- |
Net cash from financing operations | 49.58%-2B | 77.70%-670.56M | -81.74%-1.18B | -274.28%-2.73B | -448.97%-3.96B | -466.69%-3.01B | -201.00%-650.33M | 175.05%1.56B | 154.41%1.13B | 178.49%819.88M |
Effect of rate | -91.60%8.28M | -55.65%80.99M | 498.12%32.18M | -70.86%52.02M | -25.35%98.53M | 166.27%182.6M | -123.01%-8.08M | 1,240.75%178.53M | 306.44%131.99M | 440.60%68.58M |
Net Cash | -182.50%-1.31B | -268.58%-1.4B | -10,444.42%-1.98B | 148.04%1.33B | 39.83%1.59B | 7,040.78%832.48M | 102.28%19.18M | 140.34%537.22M | 170.12%1.14B | 98.90%-11.99M |
Begining period cash | 32.67%5.62B | 32.67%5.62B | 32.67%5.62B | 20.32%4.24B | 20.32%4.24B | 20.28%4.24B | 20.32%4.24B | -27.67%3.52B | -27.67%3.52B | -27.64%3.52B |
Cash at the end | -27.13%4.32B | -18.14%4.3B | -13.62%3.67B | 32.67%5.62B | 23.69%5.93B | 46.72%5.25B | 56.52%4.25B | 20.32%4.24B | 46.07%4.79B | -4.73%3.58B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data